Literature DB >> 10657388

Evaluation of seven commercial ELISA kits compared with the C1q solid-phase binding RIA for detection of circulating immune complexes.

E Van Hoeyveld1, X Bossuyt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10657388

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.

Authors:  Darius Ghaderi; Rachel E Taylor; Vered Padler-Karavani; Sandra Diaz; Ajit Varki
Journal:  Nat Biotechnol       Date:  2010-07-25       Impact factor: 54.908

2.  Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum.

Authors:  Skyler P Dillon; Anil D'Souza; Biji T Kurien; R Hal Scofield
Journal:  Biotechnol J       Date:  2009-08       Impact factor: 4.677

Review 3.  Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes.

Authors:  Murli Krishna; Steven G Nadler
Journal:  Front Immunol       Date:  2016-02-02       Impact factor: 7.561

4.  Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Helena Tyden; Christian Lood
Journal:  Arthritis Res Ther       Date:  2020-05-29       Impact factor: 5.156

5.  IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a Fc-Fc-dependent mechanism.

Authors:  Ulrich F Prodjinotho; Achim Hoerauf; Tomabu Adjobimey
Journal:  Parasitol Res       Date:  2019-09-04       Impact factor: 2.289
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.